Chemical stabilization of γ-polyglutamate by chitosan and the effect of co-solvents on the stability
Language English Country Netherlands Media print-electronic
Document type Journal Article
PubMed
33964508
DOI
10.1016/j.bpc.2021.106605
PII: S0301-4622(21)00087-9
Knihovny.cz E-resources
- Keywords
- Chemical stabilization, Chitosan, Protein folding, pH depending structure, γ-polyglutamic acid,
- MeSH
- Chitosan * chemistry MeSH
- Hydrogen-Ion Concentration MeSH
- Polyglutamic Acid * chemistry analogs & derivatives MeSH
- Solvents chemistry MeSH
- Protein Stability MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Chitosan * MeSH
- Polyglutamic Acid * MeSH
- poly(gamma-glutamic acid) MeSH Browser
- Solvents MeSH
In protein-based formulations, conformational distortions and attractive interactions may cause insoluble and undesired aggregates. In the case of ionic peptides, including cationic or anionic, commonly electrostatic interactions are the main factors that control structure assembling. In this study, it was proposed that grafting of chitosan (CS) to γ-polyglutamic acid (γ-PGA) might exhibit much strong inhibiting effect on the formation of protein aggregates due to multiple amino groups and hydrophilic properties. To guarantee stable and safe biopharmaceutical formulation, the potency of a variety of stabilizers including sugars (glucose, sucrose), polyols (sorbitol, glycerol), surfactant (Tween 20), salting-out salt (PBS), and also different pH values have been evaluated on stabilizing or destabilizing the native state of CS-g-PGA copolymer using FTIR, CD, DLS, and SDS-PAGE. The comparable analysis revealed that the stability of CS-g-PGA was strongly dependent on pH owing to the polyelectrolyte characteristics of the polymers. Altogether these results implied that CS at optimized conditions might be an important precursor for the pharmaceutical industry and function as a new polymer for aggregation suppression and protein stabilization.
References provided by Crossref.org
Whey Protein Isolate-Chitosan PolyElectrolyte Nanoparticles as a Drug Delivery System